DABIGATRAN Sandoz caps 110 mg 180 pce
7680686580022
CH-68658
B01AE07
06.03.0.
Active substances:
1 / 3
google
Details
- Product number
- 6865801
- CPT
- -
- Packaging group
- 180
- Unit
- Kapsel(n)
- Composition
- dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas, acidum tartaricum, hypromellosum, talcum, hydroxypropylcellulosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: hypromellosum, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.7 mg.
Articles (1)
Dabigatran Sandoz 110 mg, Hartkapseln
Kapseln
180
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dabigatranum etexilatum
|
110.0 MG | Substance | Wirkstoff (Principe actif) |
|
dabigatrani etexilati mesilas
|
- | Substance | WIZUS |
|
acidum tartaricum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
lacca
|
- | Substance | HNIDK |
|
propylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
kalii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
0.7 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 150.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2023
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68658
- Drug name
- Dabigatran Sandoz, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- B01AE07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/06/2023
- Authorization expiration date
- 06/06/2028
- IT number
- 06.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DABIGATRAN Sandoz caps 110 mg 180 pce
- Description (DE)
- DABIGATRAN Sandoz Kaps 110 mg 180 Stk
- Market launch
- 07/06/2023
- Narcotic (BTM)
- No